Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Brois, D. W.
Right arrow Articles by Lambert, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brois, D. W.
Right arrow Articles by Lambert, M. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 9, 1845-1853, September 1999
© 1999 Oxford University Press


Carcinogenesis

A deficiency in a 230 kDa DNA repair protein in Fanconi anemia complementation group A cells is corrected by the FANCA cDNA

Daniel W. Brois, Laura W. McMahon, Nydia I. Ramos, Lynn M. Anglin, Christopher E. Walsh1 and Muriel W. Lambert2

Department of Pathology and Laboratory Medicine, UMDNJ–New Jersey Medical School, 185 South Orange Avenue, Newark, NJ 07103 and the Graduate School of Biomedical Sciences, Newark, NJ and
1 UNC Gene Therapy Center, University of North Carolina, Chapel Hill, NC 27599, USA

Cells from individuals with the cancer-prone, inherited disorder Fanconi anemia (FA) are hypersensitive to DNA interstrand cross-linking agents and this hypersensitivity correlates with a defect in ability to repair this type of damage to their DNA. We have isolated a DNA endonuclease complex from the nuclei of normal human cells which is involved in repair of DNA interstrand cross-links and have shown that in FA complementation group A (FA-A) cells there is a defect in ability of this complex to incise DNA containing interstrand cross-links. In order to identify the specific protein(s) in this complex which is defective in FA-A cells, monoclonal antibodies (mAbs) were developed against proteins in the normal complex. One of these mAbs, which is against a protein with a molecular weight of ~230 kDa, completely inhibited the ability of the normal complex to incise cross-linked DNA. Western blot analysis has shown that there is a deficiency in this protein in FA-A cells. Electophoretic analysis has also indicated that there are reduced levels of this protein in FA-A compared with normal cells. Studies carried out utilizing FA-A cells which have been stably transduced with a retroviral vector expressing the FANCA cDNA have shown that the DNA repair defect in these cells has been corrected; levels of unscheduled DNA synthesis are at least as great as those of normal human cells. In addition, in the transduced cells the deficiency in the 230 kDa protein has been corrected, as determined by both western blot and electrophoretic analysis. These results indicate that the FANCA gene plays a role in the expression or stability of the 230 kDa protein.

Abbreviations: BCIP-NBT, 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazolium; CS, Cockayne syndrome; FA, Fanconi anemia; FA-A, Fanconi anemia complementation group A; mAb, monoclonal antibody; MMC, mitomycin C; 8-MOP, 8-methoxypsoralen; NER, nucleotide excision repair; PBS, phosphate-buffered saline; TMP, 4,5',8-trimethylpsoralen; UDS, unscheduled DNA synthesis.

2 To whom correspondence should be addressed Email: mlambert{at}umdnj.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Cell Sci.Home page
D. Sridharan, M. Brown, W. C. Lambert, L. W. McMahon, and M. W. Lambert
Nonerythroid {alpha}II spectrin is required for recruitment of FANCA and XPF to nuclear foci induced by DNA interstrand cross-links
J. Cell Sci., March 1, 2003; 116(5): 823 - 835.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R. Kumaresan and M. W. Lambert
Fanconi anemia, complementation group A, cells are defective in ability to produce incisions at sites of psoralen interstrand cross-links
Carcinogenesis, April 1, 2000; 21(4): 741 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. W. McMahon, C. E. Walsh, and M. W. Lambert
Human alpha Spectrin II and the Fanconi Anemia Proteins FANCA and FANCC Interact to Form a Nuclear Complex
J. Biol. Chem., November 12, 1999; 274(46): 32904 - 32908.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. T. Tse, J. Tang, O. Jin, C. Korsgren, K. M. John, A. L. Kung, B. Gwynn, L. L. Peters, and S. E. Lux
A New Spectrin, beta IV, Has a Major Truncated Isoform That Associates with Promyelocytic Leukemia Protein Nuclear Bodies and the Nuclear Matrix
J. Biol. Chem., June 22, 2001; 276(26): 23974 - 23985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Qiao, A. Moss, and G. M. Kupfer
Fanconi Anemia Proteins Localize to Chromatin and the Nuclear Matrix in a DNA Damage- and Cell Cycle-regulated Manner
J. Biol. Chem., June 22, 2001; 276(26): 23391 - 23396.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.